G
Günther G. Steger
Researcher at Medical University of Vienna
Publications - 243
Citations - 11875
Günther G. Steger is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 41, co-authored 238 publications receiving 10859 citations. Previous affiliations of Günther G. Steger include University of Vienna.
Papers
More filters
Journal ArticleDOI
Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: four-year results of Austrian Breast Cancer Study Group (ABCSG) trial 5
Raimund Jakesz,Hubert Hausmaninger,H. Samonigg,Ernst Kubista,D. Depisch,Michael A. Fridrik,Michael Stierer,M. Gnant,Günther G. Steger,R. Kolb,G. Jatzko,F. Hofbauer,G. Reiner,P. Steindorfer +13 more
Journal ArticleDOI
Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases.
Rupert Bartsch,Anna S. Berghoff,Ursula Pluschnig,Zsuzsanna Bago-Horvath,Peter Dubsky,Andrea Rottenfusser,C. DeVries,Margaretha Rudas,Florian Fitzal,Karin Dieckmann,Robert M. Mader,Michael Gnant,Christoph C. Zielinski,Günther G. Steger +13 more
TL;DR: This retrospective single-centre study suggests that the introduction of lapatinib improved survival in patients with BM from HER2-positive breast cancer.
Journal ArticleDOI
Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial.
M. Hejna,Wolfgang J. Köstler,Markus Raderer,Günther G. Steger,T. Brodowicz,Werner Scheithauer,Christoph Wiltschke,Christoph C. Zielinski +7 more
TL;DR: It is concluded that the topical application of GM-CSF by mouthwash significantly abbreviated the duration and relieved patients from symptoms of chemotherapy-induced mucositis and was superior to thetopical application of AA.
Journal ArticleDOI
Expression of Cell Cycle Regulatory Proteins in Breast Carcinomas Before and After Preoperative Chemotherapy
Gudrun Pohl,Margaretha Rudas,Susanne Taucher,Thomas Stranzl,Günther G. Steger,Raimund Jakesz,Robert Pirker,Martin Filipits +7 more
TL;DR: In this article, the relationship between the expression of cell cycle regulatory proteins and clinical outcome in breast cancer patients receiving preoperative chemotherapy was determined in breast carcinomas by means of immunohistochemistry both prior and after pre-operative chemotherapy.
Journal ArticleDOI
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
Günther G. Steger,Richard Greil,A. Lang,Margarethe Rudas,Florian Fitzal,Brigitte Mlineritsch,B.L. Hartmann,Rupert Bartsch,Elisabeth Melbinger,Michael Hubalek,Herbert Stoeger,Peter Dubsky,S. Ressler,A. Petzer,Christian F. Singer,C. Muss,Raimund Jakesz,Simon Peter Gampenrieder,Christoph C. Zielinski,Christian Fesl,Michael Gnant +20 more
TL;DR: The findings show that the integration of C into a neoadjuvant taxane-/anthracycline-based regimen is a feasible, safe, and effective treatment option, with incorporation of trastuzumab in HER2-positive disease.